As of August 30, 2026, the FDA's 2026 novel-drug approvals list shows no new acne therapy through August 28. The main developments are easier access to an existing combination gel and an FDA request for updated isotretinoin labeling. "Jawline acne" means persistent breakouts across the chin, lower face, or jaw. This pattern can suggest hormonal acne, particularly when flares predictably occur before menstrual periods, but location alone does not establish the cause.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Official resources:
- Testing and recalls — Use this primary source to verify the official announcement.
- Novel approvals — Use this primary source to verify the official announcement.
Table of Contents
- What changed at the FDA?
- Does a jawline pattern mean the acne is hormonal?
- Which treatments have the strongest dermatology support?
- What safety issues deserve attention?
- What should you do next?
What changed at the FDA?
On May 22, 2026, the FDA switched Differin Epiduo acne Gel from prescription to nonprescription status. The gel combines adapalene 0.1%, a topical retinoid, with benzoyl peroxide 2.5%. It is indicated for adults and children aged 12 and older, according to the FDA's prescription-to-nonprescription switch list. This change affects access rather than creating a jawline-specific treatment.
It gives eligible consumers another over-the-counter option containing two ingredients already used in acne care. In June, the FDA also requested updated labels for generic isotretinoin because newer evidence was missing from existing labeling. This was a labeling action, not a new approval. Isotretinoin remains intended for severe, treatment-resistant nodular acne and carries embryo-fetal toxicity risks managed through a safety program called REMS.
Does a jawline pattern mean the acne is hormonal?
Dermatologists consider stubborn acne on the chin, jawline, lower face, or neck consistent with hormonal acne in some women. Predictable premenstrual flares make that explanation more plausible. The American Academy of dermatology says women with this pattern may respond to combined oral contraceptives or spironolactone. Spironolactone may be considered when other treatments have failed, but treatment still depends on the individual.
People who can become pregnant need contraception while taking it because of serious birth-defect risk, as explained in the AAD's hormonal acne treatment guidance. Jawline breakouts are not always ordinary acne. The AAD advises medical assessment when acne occurs with irregular periods, facial hair, hair loss, or darkened and thickened skin. That combination can indicate polycystic ovary syndrome, or PCOS.
Which treatments have the strongest dermatology support?
The AAD's updated acne guideline strongly recommends topical retinoids and benzoyl peroxide, along with appropriate antibiotic treatment. Retinoids help prevent clogged pores, while benzoyl peroxide is commonly included in acne regimens. When antibiotics are used, the guideline advises combining them with benzoyl peroxide and limiting antibiotic exposure where possible.
This approach helps reduce antibiotic resistance. The guideline conditionally recommends topical clascoterone, which addresses hormonal causes of acne. Combined oral contraceptives and spironolactone also receive conditional recommendations. "Conditional" means the choice depends more heavily on the person's health, preferences, risks, and previous treatment results.
What safety issues deserve attention?
Benzoyl peroxide remains a recommended acne treatment, but storage conditions matter. The FDA says it can degrade into benzene under conditions such as extreme heat. Avoid leaving benzoyl peroxide products where they may become excessively hot. In 2025, FDA testing found elevated benzene in six of 95 tested products.
More than 90% had undetectable or extremely low levels, and the FDA described the related recalls as limited, according to its benzoyl peroxide testing update. Pregnancy considerations also affect treatment selection. Spironolactone requires contraception for people who can become pregnant, while isotretinoin carries embryo-fetal toxicity risks and REMS requirements. These medicines should not be treated as interchangeable with an over-the-counter topical product.
What should you do next?
Match the next step to the pattern and severity rather than relying on the word "jawline" alone: Bring the exact names and strengths of treatments already tried to an appointment. "Adapalene 0.1% with benzoyl peroxide 2.5%" gives a clinician more useful information than "an acne gel.".
- Note whether breakouts predictably worsen before menstrual periods.
- Record any irregular periods, facial hair, hair loss, or darkened and thickened skin.
- If considering nonprescription Differin Epiduo Acne Gel, confirm that the user is at least 12.
- Protect benzoyl peroxide products from extreme heat.
- Ask a dermatologist about hormonal therapy when lower-face acne remains stubborn after other treatment.